phosphatidylcholines has been researched along with ginsenoside rh1 in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (ginsenoside rh1) | Trials (ginsenoside rh1) | Recent Studies (post-2010) (ginsenoside rh1) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 70 | 0 | 45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, L; Chen, XJ; Dong, XQ; Li, MG; Liang, H; Liu, WJ; Ma, LQ; Wen, ML; Wu, SM; Zhao, JY; Zhu, YZ; Zou, CG | 1 |
1 other study(ies) available for phosphatidylcholines and ginsenoside rh1
| Article | Year |
|---|---|
Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats.
Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Ginsenosides; Liver Function Tests; Male; Non-alcoholic Fatty Liver Disease; Phosphatidylcholines; Rats; Tissue Inhibitor of Metalloproteinase-1 | 2017 |